Teixobactin, which kills a range of pathogens without detectable resistance, was isolated from microorganisms found in soil - the natural source of nearly all antibiotics developed since the 1940s, researchers said.
Last year, the discovery of the antibiotic Teixobactin by researchers in the US was hailed as a 'game-changer' in the fight against antimicrobial resistance, they said.
In order for it to be developed as a potential drug treatment, several versions of the antibiotic must be produced via chemical synthesis in order to overcome the hurdles of drug development.
"Teixobactin originally evolved in soil to kill the bacteria around it, so our challenge was to produce the antibiotic synthetically," said Ishwar Singh from University of Lincoln.
"The method we created to do this uses commercially available 'building blocks' and has a single purification step," said Singh.
"We are now able to present the total synthesis of two derivatives of Teixobactin," he said.
"We have also been able to identify some of the properties of the antibiotic which are critical for its antimicrobial activities," he said.
The bacteria against which Teixobactin is effective have, thus far, not shown any detectable resistance and given its mechanisms of attack, scientists are also confident that this is unlikely to occur in the future.
"The process of bringing an antibiotic to clinic is an extremely lengthy one and can often take around 10-15 years," said Singh.
The findings were published in the Royal Society of Chemistry journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
